Kathmandu, January 10
Nepal is hosting the clinical trial of a Covid-19 vaccine developed by a South Korean company, informs the Nepal Health Research Council.
The vaccine development by the International Vaccine Institute will be tested at Tribhuvan University Teaching Hospital in Kathmandu and Dhulikhel Hospital in Kavre.
The ethical board of the council has already endorsed the proposal for the trial and is waiting for the cabinet’s endorsement, according to the NHRC Member-Secretary Dr Pradeep Gyawali as reported by Himalaya Television.
Around 1,800 people will receive this vaccine under the trial in Nepal. Dr Laxman Shrestha and Dr Divya Singh Shah among other doctors will conduct the trial.
Dr Shrestha says the trial will begin within a few days.
